SCHEMBL16776166

SCHEMBL16776166

CCCCCCCCCCCCCCc1ccc(CC(C)=O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.70
HSD17B10 Q99714 2/20 0.61
HPGD P15428 1/20 0.61
THRA P10827 5/20 0.60
THRB P10828 5/20 0.60
ESR1 P03372 2/20 0.60
ADRA2A P08913 2/20 0.60
ADORA3 P0DMS8 2/20 0.60
TACR2 P21452 2/20 0.60
SLC6A2 P23975 2/20 0.60
SLC6A4 P31645 2/20 0.60
SLC6A3 Q01959 2/20 0.60
KDM4E B2RXH2 1/20 0.60
LMNA P02545 1/20 0.60
SHBG P04278 1/20 0.60
TP53 P04637 1/20 0.60
CYP3A4 P08684 1/20 0.60
HSPD1 P10809 1/20 0.60
ADRB3 P13945 1/20 0.60
HTR2C P28335 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30110959 1.00 ALDH1A1 (0.70) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL18527374 0.98 ALDH1A1 (0.72) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL11271830 0.92 ALDH1A1 (0.71) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL12967436 0.92 THRA (0.60) ALDH1A1THRATHRBRARBMEN1
SCHEMBL28943035 0.87 ALDH1A1 (0.55) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL16267306 0.86 ALDH1A1 (0.72) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL6801680 0.85 ALDH1A1 (0.96) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL8337401 0.85 ALDH1A1 (0.96) ALDH1A1HSD17B10HPGDTHRATHRB
SCHEMBL19166899 0.85 GPR84 (0.70) ALDH1A1HSD17B10THRATHRBESR1
SCHEMBL2674656 0.85 ALDH1A1 (0.96) ALDH1A1HSD17B10HPGDTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150152108-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152108-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 ALDH1A1 1726/4885HSD17B10 2085/4885HPGD 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.